Concepedia

Pooled Data Analysis of the Long-Term Treatment Effects of Tolvaptan in ADPKD

Xiaolei Zhou, Eric Davenport, John Ouyang, Molly E. Hoke, Diana Garbinsky, Indra Agarwal, Holly B. Krasa, Dorothee Oberdhan

Kidney International Reports · 2022 · 17 citations · 27 references

DOIFull text

Open access

Abstract

Comparison of a pooled tolvaptan cohort to a pooled control cohort with ADPKD supports longer-term treatment effects of tolvaptan.

References

27

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

Saulo Klahr, Andrew S. Levey, Gerald J. Beck et al. · New England Journal of Medicine · 1994 · 2.3K citations · Full text

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.5K citations · Full text

Volume Progression in Polycystic Kidney Disease

Jared J. Grantham, Vicente E. Torres, Arlene B. Chapman et al. · New England Journal of Medicine · 2006 · 775 citations · Full text

In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?

Crystal C. Tyson, Thomas M. Coffman · ˜The œNephron journals/Nephron journals · 2017 · 710 citations · Full text

Comparison of phenotypes of polycystic kidney disease types 1 and 2

Nick Hateboer, Marjan A. van Dijk, Nadja Bogdanova et al. · The Lancet · 1999 · 621 citations

, , +10